Rectal Adenocarcinoma Clinical Trials
3 recruiting trials for Rectal Adenocarcinoma. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT06854679
Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided Radiotherapy
Standard radiotherapy in the UK involves having daily chemotherapy tablets with radiotherapy treatment for 5 weeks at a dose of 52.5Gy to the rectal cancer over 25 fractions. This...
Sponsor: Royal Marsden NHS Foundation TrustEnrolling: 131 location
RECRUITINGPhase 2NCT07198165
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
This study aims to evaluate the efficacy and safety of short-course radiotherapy combined with CAPOX plus bevacizumab with or without a PD-1 inhibitor in patients with locally...
Sponsor: Ruijin HospitalEnrolling: 1041 location
RECRUITINGNCT05081024
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
This study measures the levels of circulating tumor DNA (ctDNA) in patients with stage II-III rectal cancer before, during, and after treatment to find out if the presence or...
Sponsor: OHSU Knight Cancer InstituteEnrolling: 502 locations